CARDIOVASCULAR DISEASES

Health Evidence Bulletins - Wales (logo)

SUBJECT INDEX

A B C D E F G H I J K

L

M N O P Q R S T U V W X

Y

Z

A

Abciximab therapy, for patients with unstable angina undergoing PTCA
Abdominal aortic aneurysm
aortic grafts
beta-blockade to reduce rate of aortic dilatation
screening
Air pollution, effect of
Alcohol consumption, and cardiovascular risk
Aminophylline, for stroke
Amiodarone
for myocardial infarction
Angina, stable
antiplatelet therapy
in secondary prevention
post-CABG
post-PTCA and post-CABG
coronary artery bypass grafting (CABG)
in symptom relief
versus PTCA
drug therapy
ECG and exercise testing
guidelines
laser angioplasty, rotational and directional coronary atherectomy
lipid lowering therapy

Top

percutaneous transluminal coronary angioplasty (PTCA)

calcium antagonists & fish oils following
in symptom relief
with elective stenting
radionucleide imaging
secondary prevention
smoking
Angina, unstable See Unstable angina
Angioplasty
for carotid stenosis
for peripheral vascular disease
for intermittent claudication
guidelines
Angiotensin converting enzyme (ACE) inhibitors
for heart failure
for myocardial infarction
Ankle brachial pressure index
Anticoagulation
cardioversion for atrial fibrillation following, in heart failure
for atrial fibrillation
for heart failure
for stroke
post-stenting in stable angina
vs aspirin for stroke

Top

Antiplatelet therapy See also aspirin

for acute myocardial infarction
for peripheral vascular disease
for previous myocardial infarction
for stable angina
prophylactic, for deep vein thrombosis
vs clopidogrel for myocardial infarction
for stroke
clopidogrel vs aspirin in secondary prevention
effect on outcomes
in secondary prevention
with aspirin in acute stroke
for unstable angina
in primary prevention
for atrial fibrillation
in low risk patients
post-CABG
reduction of MI, stroke or vascular death
reduction of re-occlusion rates
post-PTCR
to prevent deep vein thrombosis

Top

Aortic aneurysm and peripheral vascular disease

Aortic grafts
Arrhythmias, See also atrial fibrillation cardioverter defibrillators and pacemakers
Aspirin See also Antiplatelet therapy
and smoking cessation
cost-effectiveness with simvastatin and pravastatin for myocardial infarction
for acute myocardial infarction
for non-rheumatic atrial fibrillation
for secondary prevention of peripheral vascular disease 
for stable angina
for stroke
for unstable angina
ticlopidine and clopidogrel vs aspirin in myocardial infarction
ticlopidine and clopidogrel vs aspirin in secondary prevention of stroke and other outcomes 
with heparin for myocardial infarction
with heparin for unstable angina
with simvastatin for myocardial infarction
Aspirin and heparin, for unstable angina
Atrial fibrillation
guidelines
risk factor for stroke

Top

B

Beta-blockers
for heart failure
for myocardial infarction
Bisoprolol
for angina
Bystander cardio-pulmonary resuscitation (CPR)

C

Calcium supplements, to reduce blood pressure
Cardiac rehabilitation
exercise training for
guidelines
psychosocial interventions
smoking reduction
Cardiac transplantation, for heart failure
Cardiomyoplasty, for heart failure
Cardioversion, for heart failure/atrial fibrillation,
Cardioverter defibrillators, implantable
Carotid angioplasty
Carotid bruits, in the diagnosis of carotid stenosis
Carotid endarterectomy
carotid patching
for adult patients with carotid stenosis
for severe carotid stenosis
guidelines
routine shunting in
Carotid imaging, for stroke
Carotid stenosis
Carotid stents

Top

Cholesterol

effect of psychosocial interventions
for peripheral vascular disease
reduction, in primary prevention
reduction, in secondary prevention
relationship with cardiovascular morbidity
Clinical guidelines. See Guidelines
Clopidogrel. See also antiplatelet therapy
 vs aspirin for the secondary prevention of myocardial infarction
 vs aspirin for the secondary prevention of peripheral vascular disease
CAPRIE trial
Cochrane review
 vs aspirin in secondary prevention of stroke
Compression therapy, for venous leg ulcers
4-layer bandaging
importance of clinical assessement to prevent inappropriate use
in post-operative prevention of deep vein thrombosis
intermittent pneumatic compression
specialist vascular assessment to determine most appropriate use
Congenital heart disease
echocardiograph
extended mid-trimester fetal echocardiography
guidelines

Top

Coronary artery bypass grafting (CABG)

for heart failure
for stable angina
for unstable angina
Coronary atherectomy
for angina
Coronary heart disease. See also Myocardial infarction
guidelines for the
management of atrial fibrillation
prevention of coronary heart disease
Coronary revascularisation, for unstable angina
Coronary stents
Corticosteroids, for stroke
Cost effectiveness
angiotensin converting enzyme (ACE) inhibitors, in heart failure
cardiac catheterisation strategy, in unstable angina
cardiac rehabilitation
coronary stents
PTCA or CABG vs medical therapy, in stable angina
PTCA vs CABG, in stable angina
simvastatin and prevastatin, in secondary prevention
statins, in primary prevention
CT brain scanning. See Diagnostic imaging

Top

D

D-dimer testing, in the diagnosis of deep vein thrombosis
Deep vein thrombosis
drug therapy
guidelines for the prophylaxis of venous thromboembolism
secondary prevention
Defibrillation, basic and advanced life support, for myocardial infarction
Diabetes, as risk factor for cardiovascular disease
Diagnostic imaging
for angina
for congenital heart disease
for deep vein thrombosis
for heart failure
for leg ulcer
for stroke
carotid imaging
Digoxin, for heart failure
Dipyridamole, synergistic effect of aspirin with in stroke
Diuretics, for heart failure
Dysphagia, after stroke

 

E

Top

Echocardiography
extended mid-trimester fetal, for congenital heart disease
for assessement of heart disease
guidelines
in the evaluation of heart failure
Electrical stimulation
for leg ulcers
Electrocardiograph (ECG) and exercise testing
Exercise,
for intermittent claudication
to reduce cardiovascular risk
Exercise training, for cardiac rehabilitation
Extracranial-intracranial arterial anastomosis (EC/IC bypass)

 

F

Femoro-popliteal bypass surgery
Fibrinogen depleting agents, for stroke

Top

G

Glycerol treatment, for stroke
Glycoprotein IIb/IIIa inhibitors
in addition to aspirin and ticlopidine in stenting for stable angina
trials of in treatment of unstable angina
Guidelines
angina
atrial fibrillation, management
cardiac rehabilitation
cardiac pacemakers and implantable cardioverter defibrillators
chronic leg ulcer
congenital heart disease
coronary heart disease
dysphagia mangement, after stroke
echocardiography
exercise testing
heart failure
hypertension, management
myocardial infarction
myocardial infarction, pre-hospital management
peripheral vascular disease, drug therapy
prophylaxis of venous thromboembolism
radionucleide myocardial perfusion imaging
rehabilitation, after stroke
unstable angina
valvular heart disease
 

H

Top

Haemodilution
for peripheral vascular disease
for stroke
Heart failure
cardiac transplantation
cardiomyoplasty
coronary artery bypass grafting
drug therapy
echocardiography
guidelines
immunisation, influenza and pneumococcal
surgical management
Heparin.
[See also antiplatelet therapy,
anticoagulant therapy,
low molecular weight heparins]
for myocardial infarction
for primary prevention of deep vein thrombosis
for secondary prevention of deep vein thrombosis
for treatment of deep vein thrombosis
for venous thromboembolism
for unstable angina
during acute phase
with long-term aspirin
risk of thrombocytopenia
Heparin and aspirin, for unstable angina
during acute phase
in long-term
Hirudin vs heparin for myocardial infarction
Hypertension
as risk factor for stroke and coronary heart disease
guidelines
in diabetes

Top

I

Ibopamine, for heart failure
Iloprost, for peripheral vascular disease
Immunisation, influenza and pneumococcal, for patients with heart failure
Implantable cardioverter defibrillator
Intermittent claudication
angioplasty
exercise for
Intracerebral haematoma

 

L

Laser angioplasty, for angina
Laser therapy, for leg ulcers
Leg ulcers
clinical assessment
compression therapy
diagnostic imaging
dressings
drug therapy
oral zinc sulphate
stanozolol or rutoside
guidelines
laser therapy and electrical stimulation
leg ulcer clinics
topical analgesics, topical anaesthetics and dressings
ultrasound to enhance healing
Lipid-lowering therapy, See cholesterol
Losartan, for heart failure
Lovastatin, for secondary prevention
Low molecular weight heparins See also Heparins
in prevention of deep vein thrombosis
in stroke
in acute phase
vs aspirin
in treatment of deep vein thrombosis
in unstable angina

 

M

Top

Magnesium sulphate, in myocardial infarction
Magnetic resonance imaging (MRI). See Diagnostic imaging
Mannitol, for stroke
Mononitrate therapy
for myocardial infarction
MRI scanning. See Diagnostic imaging
Myocardial infarction
bystander cardio-pulmonary resuscitation
cardiac rehabilitation
drug therapy
guidelines for management
guidelines for pre-hospital management
guidelines for the prevention of coronary heart disease
out-of-hospital defibrillation, basic and advanced life support
patient education
percutaneous transluminal coronary angioplasty (PTCA) for
secondary prevention
thrombolytic therapy
Myocardial perfusion imaging, See Diagnostic imaging

 

N

Top

Nifedipine
for myocardial infarction
Nimodipine, for stroke
 

O

Obesity
as risk factor for angina, myocardial infarction or stroke
as risk factor for leg ulceration

 

P

Top

Pacemakers
Patient education, for patients with coronary heart disease
Pentoxifylline
for peripheral vascular disease
Cochrane review
vs exercise
for stroke
Percutaneous transluminal coronary angioplasty (PTCA)
and abciximal in unstable angina
and smoking risk
antiplatelet therapy following
in reduction of myocardial infarction, stroke or vascular death
in reduction of re-occlusion rates
calcium antagonists and fish oils, following
with elective stenting,for angina
immediate,for myocardial infarction

Top

Peripheral vascular disease

drug therapy
drug therapy, guidelines
lipid-lowering therapy
secondary prevention
smoking cessation
surgical management
Phosphodiesterase inhibitors, for heart failure
Physical activity, See Exercise
Potassium supplements, to reduce blood pressure
Pravastatin
for primary prevention
for secondary prevention
cost-effectiveness
risk reduction
Prevention of cardiovascular disease
air pollution
alcohol consumption
anticoagulation for atrial fibrillation
antiplatelet therapy
cholesterol
glycaemic control in diabetes
guidelines for prevention of coronary heart disease
hypertension
obesity
oral potassium supplements
physical activity
smoking, active and passive
sodium intake
treatment of hypertension in diabetes
weight loss
Propentofylline, for stroke
Prostacyclin, for stroke
Psychosocial interventions
within cardiac rehabilitation schemes

 

R

Top

Radionucleide imaging, See Diagnostic imaging
Rutoside, for leg ulcers

 

S

Simvastatin, for secondary prevention
cost-effectiveness
risk reduction
Smoking
and pravastatin therapy for cholesterol reduction
and pravastatin therapy for myocardial infarction
and risk of coronary heart or peripheral vascular disease
and risk of death following PTCA
cessation as protective effect compared to exercise
cost-effectiveness of statins with smoking cessation in primary prevention
cost-effectiveness of statins with smoking cessation in secondary prevention
effect of cessation on intermittent claudication
effect on cessation of multifactorial cardiac rehabilitation
passive
Sodium intake, and hypertension
Stanozolol, for leg ulcers
Statins
for the primary prevention of myocardial infarction
lovastatin
pravastatin
for the secondary prevention of myocardial infarction
cost-effectiveness of statins
pravastatin
simvastatin
Stents, coronary

Top

Stroke

carotid stenosis
diagnostic imaging
drug therapy
dysphagia, guidelines
multidisciplinary assessment
rehabilitation, guidelines
remedial therapy
secondary prevention
stroke unit care
surgical management
thrombolytic therapy
venous thromboembolism, prevention

 

T

Theophylline, for stroke
Therapy services, for stroke
Thrombocytopenia
Thromboembolism, venous, prevention in stroke
Thrombolytic therapy
for myocardial infarction
for stroke
for unstable angina
Thrombophilia
Ticlopidine
and clopidogrel vs aspirin for secondary prevention of myocardial infarction
and clopidogrel vs aspirin for secondary prevention of peripheral vascular disease
and clopidogrel vs aspirin for secondary prevention of stroke

 

U

Top

Ultrasonography
in the diagnosis of deep vein thrombosis
vs angiography in assessment of carotid stenosis
Unstable angina
antiplatelet and anticoagulant therapy
coronary revascularisation
early invasive vs early conservative strategies
guidelines
thrombolytic therapy

 

V

Valvular heart disease
management guidelines
Varicose veins and leg ulcers clinical assessment
compression therapy
guidelines
surgical management
Vasoactive drugs, for stroke

 

W

Warfarin
comparison with aspirin in prevention of stroke
Weight loss

 

Z

Zinc sulphate, oral for leg ulcers
 
Top

Contents Home

Health Evidence Bulletins: Wales, Duthie Library, UWCM, Cardiff CF14 4XN. e-mail: weightmanal@cardiff.ac.uk